Skip to content

Drug interactions

Darifenacin + Idelalisib

Severity: Major

Darifenacin and Idelalisib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Idelalisib is a strong CYP3A4 inhibitor and can substantially increase darifenacin exposure, raising anticholinergic toxicity and QT concerns.

What this interaction means in plain words

Darifenacin and Idelalisib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Darifenacin belongs to Genitourinary; Idelalisib belongs to Oncology.

Evidence level: Moderate

Why it happens

Idelalisib strongly inhibits CYP3A4 metabolism of darifenacin.

What to do

Avoid the combination where possible and choose a bladder agent not reliant on CYP3A4. If used, keep darifenacin at 7.5 mg daily at most and monitor for anticholinergic toxicity.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Darifenacin and Idelalisib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Darifenacin with Idelalisib?

MediHelp rates the interaction as major. Darifenacin and Idelalisib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Idelalisib is a strong CYP3A4 inhibitor and can substantially increase darifenacin exposure, raising anticholinergic toxicity and QT concerns.

How serious is the interaction between Darifenacin and Idelalisib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible and choose a bladder agent not reliant on CYP3A4. If used, keep darifenacin at 7.5 mg daily at most and monitor for anticholinergic toxicity.

What other medicines interact with Darifenacin?

MediHelp also lists interactions of Darifenacin with, for example, Atazanavir, Bethanechol, Clarithromycin. The full list is on the Darifenacin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in